About Bridge

BRIDGE - Bringing Rheumatology & ILD Discipline into Global Education - is a digital educational program developed to strengthen the practical application of the 2023 ACR/CHEST Guideline for the screening and monitoring of Interstitial Lung Disease (ILD) in individuals with systemic autoimmune rheumatic diseases (SARDs).
Through its carefully curated curriculum, BRIDGE translates global guideline recommendations into structured, clinically relevant learning. The program integrates expert insights, real‑world case scenarios, and concise reference tools to support consistent, evidence‑aligned decision‑making in daily practice.
Delivered via a flexible, self‑paced digital platform, BRIDGE offers expert‑led sessions, case‑based learning, clinical algorithms, and assessments - allowing clinicians to engage with the content at their convenience while reinforcing high‑quality, guideline‑based care.
banner
banner

About CHEST

CHEST is the Global Leader in advancing the best patient outcomes through innovative chest medicine education, clinical research, and team-based care.

Its mission is to champion the prevention, diagnosis, and treatment of Chest Diseases through education, communication, and research.

It serves as an essential connection to clinical knowledge and resources for its 19,000+ members worldwide who provide patient care in Pulmonary, Critical Care, and Sleep Medicine.

About ACR

The American College of Rheumatology (ACR) is a leading international professional organization dedicated to advancing the care of patients with rheumatic and musculoskeletal diseases through education, research, advocacy, and clinical guidance.

ACR plays a pivotal role in developing evidence-based clinical practice guidelines that support healthcare professionals worldwide in delivering high-quality, standardized care.

Its guidelines are developed through rigorous methodology, systematic evidence review, and expert consensus to ensure clinical relevance and scientific integrity.

banner